Ultragenyx Pharmaceutical RARE Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's operating margin?
- Ultragenyx Pharmaceutical (RARE) reported operating margin of -83.8% in Q1 2026.
- How has Ultragenyx Pharmaceutical's operating margin changed year-over-year?
- Ultragenyx Pharmaceutical's operating margin increased by 3.7% year-over-year, from -87% to -83.8%.
- What is the long-term trend for Ultragenyx Pharmaceutical's operating margin?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's operating margin has grown at a -8.2% compound annual growth rate (CAGR), from -121.8% to -79.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.